These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27157539)

  • 21. Will growth in cryptomarket drug buying increase the harms of illicit drugs?
    Aldridge J; Stevens A; Barratt MJ
    Addiction; 2018 May; 113(5):789-796. PubMed ID: 28766792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin.
    Quintana P; Ventura M; Grifell M; Palma A; Galindo L; Fornís I; Gil C; Carbón X; Caudevilla F; Farré M; Torrens M
    Int J Drug Policy; 2017 Feb; 40():78-83. PubMed ID: 27889114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals.
    Hughes CE; Moxham-Hall V; Ritter A; Weatherburn D; MacCoun R
    Int J Drug Policy; 2017 Mar; 41():91-100. PubMed ID: 28131615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating drug trafficking on the Tor Network: Silk Road 2, the sequel.
    Dolliver DS
    Int J Drug Policy; 2015 Nov; 26(11):1113-23. PubMed ID: 25681266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study.
    Coney L; Peacock A; Malm A; Munksgaard R; Aldridge J; Ferris JA; Maier LJ; Winstock AR; Barratt MJ
    Int J Drug Policy; 2024 Jan; 123():104258. PubMed ID: 38056221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading.
    Van Hout MC; Bingham T
    Int J Drug Policy; 2014 Mar; 25(2):183-9. PubMed ID: 24268875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis.
    Cunliffe J; Décary-Hêtu D; Pollak TA
    Int J Drug Policy; 2019 Nov; 73():263-272. PubMed ID: 30772109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A replication and methodological critique of the study "Evaluating drug trafficking on the Tor Network".
    Munksgaard R; Demant J; Branwen G
    Int J Drug Policy; 2016 Sep; 35():92-6. PubMed ID: 27079624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge.
    Bancroft A; Scott Reid P
    Int J Drug Policy; 2016 Sep; 35():42-9. PubMed ID: 26777135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs.
    Moyle L; Childs A; Coomber R; Barratt MJ
    Int J Drug Policy; 2019 Jan; 63():101-110. PubMed ID: 30530252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The recovery of online drug markets following law enforcement and other disruptions.
    Van Buskirk J; Bruno R; Dobbins T; Breen C; Burns L; Naicker S; Roxburgh A
    Drug Alcohol Depend; 2017 Apr; 173():159-162. PubMed ID: 28259089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative research in Spanish cannabis social clubs: "The moment you enter the door, you are minimising the risks".
    Belackova V; Tomkova A; Zabransky T
    Int J Drug Policy; 2016 Aug; 34():49-57. PubMed ID: 27461986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets.
    Norbutas L; Ruiter S; Corten R
    Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An ethnographic exploration of drug markets in Kisumu, Kenya.
    Syvertsen JL; Ohaga S; Agot K; Dimova M; Guise A; Rhodes T; Wagner KD
    Int J Drug Policy; 2016 Apr; 30():82-90. PubMed ID: 26838470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Selling smarter, not harder": Life course effects on drug sellers' risk perceptions and management.
    Fader JJ
    Int J Drug Policy; 2016 Oct; 36():120-9. PubMed ID: 27450317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?
    Meyers K; Kaynak Ö; Bresani E; Curtis B; McNamara A; Brownfield K; Kirby KC
    Int J Drug Policy; 2015 Jul; 26(7):670-4. PubMed ID: 25641258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium.
    van de Ven K; Mulrooney KJ
    Int J Drug Policy; 2017 Feb; 40():6-15. PubMed ID: 27574781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.